Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.69% | 21.46% | -54.79% | -15.01% | 11.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.69% | 21.46% | -54.79% | -15.01% | 11.42% |
| Cost of Revenue | -0.85% | 3.19% | -35.08% | -0.83% | 18.81% |
| Gross Profit | 16.63% | 39.39% | -74.78% | -32.60% | 7.04% |
| SG&A Expenses | -0.52% | -0.41% | -16.86% | -2.76% | 92.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.84% | -1.80% | -11.72% | -10.40% | 12.66% |
| Operating Income | 10.13% | 8.21% | 3.61% | 9.74% | -13.12% |
| Income Before Tax | 9.95% | 9.22% | 3.66% | 9.81% | -11.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.95% | 9.22% | 3.66% | 9.81% | -11.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.95% | 9.22% | 3.66% | 9.81% | -11.94% |
| EBIT | 10.13% | 8.21% | 3.61% | 9.74% | -13.12% |
| EBITDA | 10.17% | 8.17% | 3.28% | 9.87% | -14.86% |
| EPS Basic | 18.75% | 17.14% | 10.00% | 14.58% | -6.67% |
| Normalized Basic EPS | 20.00% | 18.18% | 12.00% | 13.33% | -5.26% |
| EPS Diluted | 18.75% | 17.14% | 10.00% | 14.58% | -6.67% |
| Normalized Diluted EPS | 20.00% | 18.18% | 12.00% | 13.33% | -5.26% |
| Average Basic Shares Outstanding | 13.26% | 7.71% | 7.11% | 5.99% | 5.75% |
| Average Diluted Shares Outstanding | 13.26% | 7.71% | 7.11% | 5.99% | 5.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
